|
|
|
Insider
Information: |
Maraganore John |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
263,534 |
|
Indirect Shares
|
6,153,633 |
|
|
Direct
Value |
$34,888,515 |
|
|
Indirect Value
|
$14,549,676 |
|
|
Total
Shares |
6,417,167 |
|
|
Total
Value |
$49,438,191 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Executive Office... |
2021-12-22 |
227,663 |
2021-12-22 |
3,133 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
30,028 |
|
0 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
Director |
2017-09-14 |
5,843 |
2014-07-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
154 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2015-01-26 |
4 |
B |
$95.00 |
$950,000 |
D/D |
10,000 |
122,825 |
2.81 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-08-24 |
4 |
S |
$95.13 |
$1,062,108 |
D/D |
(11,085) |
8,597 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2013-10-10 |
4 |
OE |
$6.78 |
$85,869 |
D/D |
12,665 |
31,282 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & CEO |
|
2006-05-12 |
4 |
AS |
$14.94 |
$206,933 |
D/D |
(13,322) |
5,135 |
|
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2018-09-11 |
4 |
S |
$72.52 |
$986,129 |
D/D |
(13,555) |
36,209 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-03-03 |
4 |
OE |
$0.95 |
$71,923 |
D/D |
13,839 |
18,682 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-03-03 |
4 |
S |
$85.02 |
$1,176,646 |
D/D |
(13,839) |
4,843 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-08-24 |
4 |
OE |
$2.09 |
$28,924 |
D/D |
13,839 |
19,682 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2018-09-12 |
4 |
S |
$71.74 |
$1,015,982 |
D/D |
(14,162) |
22,047 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,166 |
211,755 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,167 |
204,160 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
14,167 |
234,299 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-04-20 |
4 |
OE |
$22.75 |
$342,956 |
D/D |
15,075 |
148,464 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-04-20 |
4 |
AS |
$67.38 |
$1,017,773 |
D/D |
(15,075) |
133,389 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2016-07-20 |
4 |
OE |
$22.75 |
$342,956 |
D/D |
15,075 |
148,464 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2016-07-20 |
4 |
AS |
$64.29 |
$988,592 |
D/D |
(15,075) |
133,389 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-01-19 |
4 |
AS |
$70.95 |
$1,116,985 |
D/D |
(15,076) |
133,389 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-01-19 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-01-20 |
4 |
AS |
$66.28 |
$1,047,234 |
D/D |
(15,076) |
133,389 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-01-20 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-04-19 |
4 |
AS |
$67.02 |
$1,016,199 |
D/D |
(15,076) |
133,389 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-04-19 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2016-07-19 |
4 |
AS |
$63.73 |
$961,998 |
D/D |
(15,076) |
133,389 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2016-07-19 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
16,236 |
222,272 |
0 |
- |
|
154 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|